CORPORATE EVENTS
March 14th, 2025 – Board of Directors’ meeting for the examination of the Financial Statements as of 31ˢᵗ December 2024.
April 16th, 2025 – Ordinary Shareholders’ meeting for the approval of the Financial Statements as of 31ˢᵗ December 2024.
May 12th, 2025 – Board of Directors’ meeting for the approval of the Interim Management Statements as of 31ˢᵗ March 2025.
September 8th, 2025 – Board of Directors’ meeting tfor the approval of the Half-Yearly Financial Report as of 30ᵗʰ June 2025.
November 10th, 2025 – Board of Directors’ meeting for the approval of the Interim Management Statements as of 30ᵗʰ September 2025.
COMMUNICATION OF REGULATED INFORMATION
Pharmanutra S.p.A. indicates that for the sending and storage of Regulated Information, use is made of the eMarket SDIR circulation system and the eMarket STORAGE mechanism managed by Spafid Connect S.p.A., with registered office in Foro Buonaparte 10, Milan.